METASTATIC UROTHELIAL CANCER
Clinical trials for METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough bladder cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab (alone or with another drug, tremelimumab) to standard chemotherapy helps people with advanced bladder cancer live longer. About 1,200 participants who have not had prior chemotherapy will receive either the drug c…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
New drug combo shows promise for tough bladder cancer
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), for people with advanced bladder cancer that has spread. The goal is to see if it helps shrink tumors or slow the disease. About 956 adults who have not had treatment or have had prior therapy …
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 11, 2026 20:39 UTC